State Ledger
Company profile

Pulmatrix, Inc. CIK 1574235

Ticker
PULM (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Framingham, MA 01701
Fiscal year end
2025 (FY)
Market Data
Close
$1.58
Change
+$0.00
Change %
0.00%
Volume
0

PULM · trading date Oct 9, 2026 · previous close $1.58 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$5.16M
Total assets
$4.14M
Total liabilities
$329.0K
Stockholders' equity
$3.81M
Cash & equivalents
$4.09M
Operating income
-$5.17M
Operating cash flow
-$5.43M
Capital expenditures
—

Fiscal year 2025, via 10-K/A filed 2026-06-16. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
7.9%
Equity / assets
92.1%
CapEx / revenue
—
Operating cash flow / net income
1.05×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$5.16M $4.14M $329.0K $3.81M
2024 $7.81M -$9.56M $9.94M $996.0K $8.95M
2023 $7.30M -$14.12M $33.96M $15.96M $18.00M
2022 $6.07M -$18.84M $40.95M $9.84M $31.11M
2021 $5.17M -$20.17M $58.82M $11.37M $47.45M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form S-4/A
2026-09-17
Financials filed via
Form 10-K/A
filed 2026-06-16

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Framingham, MA 01701
945 CONCORD STREET
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:34 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Massachusetts — Public Companies